Quest Diagnostics Incorporated (DGX)
USD 172.45
(-0.59%)
USD 172.45
(-0.59%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7.59 USD | -6.53% |
| 2022 | 8.12 USD | -48.93% |
| 2021 | 15.90 USD | 48.88% |
| 2020 | 10.68 USD | 67.4% |
| 2019 | 6.38 USD | 17.93% |
| 2018 | 5.41 USD | -3.91% |
| 2017 | 5.63 USD | 22.93% |
| 2016 | 4.58 USD | -6.91% |
| 2015 | 4.92 USD | 28.46% |
| 2014 | 3.83 USD | -31.36% |
| 2013 | 5.58 USD | 59.89% |
| 2012 | 3.49 USD | 18.31% |
| 2011 | 2.95 USD | -27.7% |
| 2010 | 4.08 USD | 4.35% |
| 2009 | 3.91 USD | 30.77% |
| 2008 | 2.99 USD | 69.89% |
| 2007 | 1.76 USD | -40.94% |
| 2006 | 2.98 USD | 9.96% |
| 2005 | 2.71 USD | 10.61% |
| 2004 | 2.45 USD | 16.11% |
| 2003 | 2.11 USD | 26.35% |
| 2002 | 1.67 USD | 91.95% |
| 2001 | 0.87 USD | 52.63% |
| 2000 | 0.57 USD | 2380.0% |
| 1999 | -0.02 USD | -110.87% |
| 1998 | 0.23 USD | 221.05% |
| 1997 | -0.19 USD | 96.44% |
| 1996 | -5.33 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 2.05 USD | 17.82% |
| 2024 Q1 | 1.74 USD | 1.75% |
| 2024 Q3 | 2.01 USD | -1.95% |
| 2023 Q2 | 2.09 USD | 16.76% |
| 2023 FY | - USD | -6.53% |
| 2023 Q1 | 1.79 USD | 101.12% |
| 2023 Q3 | 1.99 USD | -4.78% |
| 2023 Q4 | 1.71 USD | -14.07% |
| 2022 Q4 | 0.89 USD | -59.36% |
| 2022 FY | - USD | -48.93% |
| 2022 Q3 | 2.19 USD | 10.05% |
| 2022 Q2 | 1.99 USD | -33.0% |
| 2022 Q1 | 2.97 USD | -6.9% |
| 2021 FY | - USD | 48.88% |
| 2021 Q1 | 3.52 USD | -17.76% |
| 2021 Q2 | 5.05 USD | 43.47% |
| 2021 Q3 | 4.11 USD | -18.61% |
| 2021 Q4 | 3.19 USD | -22.38% |
| 2020 Q4 | 4.28 USD | 1.9% |
| 2020 Q3 | 4.20 USD | 204.35% |
| 2020 Q2 | 1.38 USD | 86.49% |
| 2020 Q1 | 0.74 USD | -60.64% |
| 2020 FY | - USD | 67.4% |
| 2019 FY | - USD | 17.93% |
| 2019 Q1 | 1.22 USD | 31.18% |
| 2019 Q2 | 1.67 USD | 36.89% |
| 2019 Q4 | 1.88 USD | 18.24% |
| 2019 Q3 | 1.59 USD | -4.79% |
| 2018 Q3 | 1.56 USD | -2.5% |
| 2018 FY | - USD | -3.91% |
| 2018 Q1 | 1.30 USD | -30.11% |
| 2018 Q2 | 1.60 USD | 23.08% |
| 2018 Q4 | 0.93 USD | -40.38% |
| 2017 Q4 | 1.86 USD | 57.63% |
| 2017 Q3 | 1.18 USD | -15.71% |
| 2017 FY | - USD | 22.93% |
| 2017 Q2 | 1.40 USD | 17.65% |
| 2017 Q1 | 1.19 USD | 7.21% |
| 2016 Q3 | 1.37 USD | -0.72% |
| 2016 Q1 | 0.71 USD | -45.8% |
| 2016 FY | - USD | -6.91% |
| 2016 Q4 | 1.11 USD | -18.98% |
| 2016 Q2 | 1.38 USD | 94.37% |
| 2015 Q1 | 0.42 USD | -67.69% |
| 2015 FY | - USD | 28.46% |
| 2015 Q4 | 1.31 USD | -44.73% |
| 2015 Q3 | 2.37 USD | 189.02% |
| 2015 Q2 | 0.82 USD | 95.24% |
| 2014 Q3 | 0.89 USD | -3.26% |
| 2014 Q4 | 1.30 USD | 46.07% |
| 2014 FY | - USD | -31.36% |
| 2014 Q1 | 0.72 USD | -25.77% |
| 2014 Q2 | 0.92 USD | 27.78% |
| 2013 Q4 | 0.97 USD | -64.07% |
| 2013 Q3 | 2.70 USD | 152.34% |
| 2013 FY | - USD | 59.89% |
| 2013 Q2 | 1.07 USD | 24.42% |
| 2013 Q1 | 0.86 USD | 145.71% |
| 2012 FY | - USD | 18.31% |
| 2012 Q1 | 1.00 USD | -16.67% |
| 2012 Q3 | 1.02 USD | -8.93% |
| 2012 Q4 | 0.35 USD | -65.69% |
| 2012 Q2 | 1.12 USD | 12.0% |
| 2011 Q4 | 1.20 USD | 11.11% |
| 2011 FY | - USD | -27.7% |
| 2011 Q1 | 0.87 USD | -15.53% |
| 2011 Q2 | 1.03 USD | 18.39% |
| 2011 Q3 | 1.08 USD | 4.85% |
| 2010 Q4 | 1.03 USD | -9.65% |
| 2010 FY | - USD | 4.35% |
| 2010 Q1 | 0.90 USD | -10.89% |
| 2010 Q2 | 1.08 USD | 20.0% |
| 2010 Q3 | 1.14 USD | 5.56% |
| 2009 Q3 | 1.03 USD | 1.98% |
| 2009 FY | - USD | 30.77% |
| 2009 Q4 | 1.01 USD | -1.94% |
| 2009 Q1 | 0.88 USD | -2.22% |
| 2009 Q2 | 1.01 USD | 14.77% |
| 2008 Q4 | 0.90 USD | 57.89% |
| 2008 Q1 | 0.72 USD | 2756.83% |
| 2008 Q2 | 0.83 USD | 15.28% |
| 2008 Q3 | 0.57 USD | -31.33% |
| 2008 FY | - USD | 69.89% |
| 2007 FY | - USD | -40.94% |
| 2007 Q2 | 0.74 USD | 34.55% |
| 2007 Q3 | 0.51 USD | -31.08% |
| 2007 Q1 | 0.55 USD | -28.57% |
| 2007 Q4 | -0.03 USD | -105.31% |
| 2006 Q4 | 0.77 USD | -4.94% |
| 2006 Q1 | 0.73 USD | 10.61% |
| 2006 Q2 | 0.67 USD | -8.22% |
| 2006 Q3 | 0.81 USD | 20.9% |
| 2006 FY | - USD | 9.96% |
| 2005 Q2 | 0.74 USD | 13.85% |
| 2005 FY | - USD | 10.61% |
| 2005 Q4 | 0.66 USD | -1.49% |
| 2005 Q1 | 0.65 USD | 4.84% |
| 2005 Q3 | 0.67 USD | -9.46% |
| 2004 Q1 | 0.56 USD | 7.69% |
| 2004 FY | - USD | 16.11% |
| 2004 Q2 | 0.62 USD | 10.71% |
| 2004 Q3 | 0.65 USD | 4.84% |
| 2004 Q4 | 0.62 USD | -4.62% |
| 2003 FY | - USD | 26.35% |
| 2003 Q4 | 0.52 USD | -8.77% |
| 2003 Q3 | 0.57 USD | 0.0% |
| 2003 Q2 | 0.57 USD | 29.55% |
| 2003 Q1 | 0.44 USD | 7.32% |
| 2002 Q2 | 0.45 USD | 28.57% |
| 2002 Q1 | 0.35 USD | 29.63% |
| 2002 Q3 | 0.45 USD | 0.0% |
| 2002 Q4 | 0.41 USD | -8.89% |
| 2002 FY | - USD | 91.95% |
| 2001 FY | - USD | 52.63% |
| 2001 Q4 | 0.27 USD | 0.0% |
| 2001 Q3 | 0.27 USD | 92.86% |
| 2001 Q2 | 0.14 USD | -30.0% |
| 2001 Q1 | 0.20 USD | 42.86% |
| 2000 FY | - USD | 2380.0% |
| 2000 Q4 | 0.14 USD | -12.5% |
| 2000 Q3 | 0.16 USD | -5.88% |
| 2000 Q1 | 0.10 USD | 221.8% |
| 2000 Q2 | 0.17 USD | 70.0% |
| 1999 Q2 | 0.11 USD | 76.0% |
| 1999 Q1 | 0.06 USD | 37.06% |
| 1999 Q4 | -0.08 USD | -26.31% |
| 1999 FY | - USD | -110.87% |
| 1999 Q3 | -0.06 USD | -159.09% |
| 1998 Q3 | 0.05 USD | -33.33% |
| 1998 Q4 | 0.05 USD | -8.8% |
| 1998 FY | - USD | 221.05% |
| 1998 Q2 | 0.08 USD | 36.36% |
| 1998 Q1 | 0.06 USD | 116.67% |
| 1997 Q2 | 0.07 USD | 100.0% |
| 1997 Q4 | -0.33 USD | -1420.0% |
| 1997 FY | - USD | 96.44% |
| 1997 Q1 | 0.04 USD | 100.87% |
| 1997 Q3 | 0.02 USD | -64.29% |
| 1996 Q4 | -4.04 USD | -292.23% |
| 1996 Q3 | -1.03 USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Agilent Technologies, Inc. | 4.22 USD | -79.858% |
| Charles River Laboratories International, Inc. | 9.27 USD | 18.123% |
| Danaher Corporation | 6.44 USD | -17.857% |
| Enzo Biochem, Inc. | -0.51 USD | 1588.235% |
| IQVIA Holdings Inc. | 7.39 USD | -2.706% |
| Laboratory Corporation of America Holdings | 4.80 USD | -58.125% |
| Mettler-Toledo International Inc. | 36.10 USD | 78.975% |
| Qiagen N.V. | 1.54 USD | -392.857% |
| Revvity, Inc. | 5.56 USD | -36.511% |
| Thermo Fisher Scientific Inc. | 15.53 USD | 51.127% |
| Waters Corporation | 10.87 USD | 30.175% |